Neurological Surgery 脳神経外科50巻5号

2022年09月発行

特集 感染症—脳神経外科医のためのエッセンス Ⅱ脳神経外科領域におけるSSIとその予防・対策

機能神経外科における感染—デバイスを用いた手術を中心に

著者： 佐々木達也¹ 安原隆雄¹ 伊達勲¹

所属機関： ¹岡山大学学術研究院医歯薬学域脳神経外科

ページ範囲：P.1027 - P.1034

Point
・デバイスを用いる手術が多い機能神経外科において，手術部位感染は最も注意すべき手術合併症である．
・感染予防としては消毒，創部の洗浄，抗菌薬の適切な使用，丁寧な縫合，そして迅速な手技が基本かつ最重要である．
・感染判明後は速やかに対応し，患者のADL，QOL低下を最小限にするためにあらゆる対策を講じる．

参考文献

1）Cabral AM, et al：Prevalence of distinct types of hardware failures related to deep brain stimulation. Neurosurg Rev 45：1123-1134, 2022

2）Kantzanou M, et al：Deep brain stimulation-related surgical site infections：a systematic review and meta-analysis. Neuromodulation 24：197-211, 2021

3）Abode-Iyamah KO, et al：Deep brain stimulation hardware-related infections：10-year experience at a single institution. J Neurosurg 130：629-638, 2019

4）Rasouli JJ, Kopell BH：The adjunctive use of vancomycin powder appears safe and may reduce the incidence of surgical-site infections after deep brain stimulation surgery. World Neurosurg 95：9-13, 2016

5）Atchley TJ, et al：Reoperation for device infection and erosion following deep brain stimulation implantable pulse generator placement. J Neurosurg 133：403-410, 2020

6）Jehi L, et al：Comparative effectiveness of stereotactic electroencephalography versus subdural grids in epilepsy surgery. Ann Neurol 90：927-939, 2021

7）Arya R, et al：Adverse events related to extraoperative invasive EEG monitoring with subdural grid electrodes：a systematic review and meta-analysis. Epilepsia 54：828-839, 2013

8）Giordano F, et al：Vagus nerve stimulation：surgical technique of implantation and revision and related morbidity. Epilepsia 58（Suppl 1）：85-90, 2017

9）Révész D, et al：Complications and safety of vagus nerve stimulation：25 years of experience at a single center. J Neurosurg Pediatr 18：97-104, 2016

10）Kahlow H, Olivecrona M：Complications of vagal nerve stimulation for drug-resistant epilepsy：a single center longitudinal study of 143 patients. Seizure 22：827-833, 2013

11）Ben-Menachem E：Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 18：415-418, 2001

12）Kuroda N, et al：Low body mass index and low intelligence quotient are infection risk factors in vagus nerve stimulation. World Neurosurg 130：e839-e45, 2019　doi：10.1016/j.wneu.2019.06.235

13）Faraj CA, et al：Salvage therapy for vagal nerve stimulator infection；literature review and report of a delayed recurrence. Clin Neurol Neurosurg 200：106333, 2021　doi：10.1016/j.clineuro.2020.106333

14）Nuru M, et al：Infectious complications and operative management of intrathecal baclofen pumps in the pediatric population：a systematic review and meta-analysis of 20 years of pooled experience. World Neurosurg 163：e59-e72, 2022　doi：10.1016/j.wneu.2022.02.078

15）Balaratnam MS, et al：Reducing intrathecal baclofen related infections：service evaluation and best practice guidelines. Neuromodulation 23：991-995, 2020

16）Necking E, et al：Complications of intrathecal drug delivery therapy（ITDD）：a retrospective study of 231 implantations between 1999 and 2014. Clin Neurol Neurosurg 205：106630, 2021　doi：10.1016/j.clineuro.2021.106630

17）Ginalis EE, et al：Is it possible to save the deep brain stimulation hardware when presenting with wound dehiscence or hardware infection? Stereotact Funct Neurosurg 99：496-505, 2021